Problems › Our Sales Cycle Is Too Long › Education & Training Providers
Long cycles usually occur because the internal contact cannot secure private investor sign-off on the enrolment numbers required to reach 11.52 m USD without losing 0.17 m USD of ebitda to support costs. For education and training providers, this shows up in a particular place. The numbers that carry the answer are 14.4 % and 71 %, and the complication specific to this industry is that to reach 13.44 m usd revenue requires 6,720 enrolments yet incremental support costs erase 0.17 m usd of ebitda. The general version of this problem and the one you are actually in have different first moves.
Long cycles usually occur because the internal contact cannot secure private investor sign-off on the enrolment numbers required to reach 11.52 m USD without losing 0.17 m USD of ebitda to support costs. For education and training providers, this shows up in a particular place. The numbers that carry the answer are 14.4 % and 71 %, and the complication specific to this industry is that to reach 13.44 m usd revenue requires 6,720 enrolments yet incremental support costs erase 0.17 m usd of ebitda. The general version of this problem and the one you are actually in have different first moves.
A cycle lengthens when it stalls after initial interest because the contact must now defend the projected enrolment yield and instructor utilisation figures to an investor who never attended the discussions and sees only the cost per learner acquired.
Shortening therefore means supplying that contact with the specific comparisons on completion rate gains and blended cohort economics that justify moving from 5,760 to 6,720 enrolments without eroding margins.
A second frequent cause is engaging only with training managers who lack authority to approve the spend, which inserts an untracked approval loop once the investor reviews the 14.4 % or 18.3 % metrics.
These three together are the signature. One on its own usually points somewhere else.
✓ Enrolment yield stops advancing past the same pipeline stage on multiple cohorts
✓ Revenue forecasts tied to 71 % completion rates keep moving later on the same opportunities
✓ Most lost bids end with no decision rather than selection of another provider
The move that usually makes it worse. Increasing follow-up calls, which adds pressure on the contact without supplying fresh data on cost per learner acquired or utilisation rates for the investor review.
It is for you if you run or finance an education and training provider and deals consistently stall at the same stage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on an education and training provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Brightsel Learning Group, a sample company profile used for testing rather than a customer — 11.52 m USD revenue from 5,760 enrolments.
Excerpt from a real Percision run · Cost Reduction & Efficiency · sample company profile
The move. Monetise the existing 48 contracts by adding regulatory add-ons delivered at the physical sites to lift ACV 25–30 % and protect margin.
| Investment required | 0.35–0.45 m USD (within the stated 0.85 m USD FY2026 cap) |
| Expected return | Base case incremental EBITDA of 0.45–0.55 m USD on 0.40 m USD investment yields 1.1–1.4× payback within 18 months; upside case reaches 1.8× if 5 new contracts are added by Month 24. |
| Revenue, year 1 | 12.4–12.7 m USD |
| Revenue, year 2 | 13.3–14.0 m USD |
| Revenue, year 3 | 14.5–15.5 m USD |
| Exit criteria | Strategy abandoned if, by Month 12, fewer than 50 % of the 48 contracts have renewed at the 25 % premium OR if instructor utilisation falls below 65 % for two consecutive quarters, signalling demand or capacity failure. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For education and training providers it works through 14.4 %, 71 %, 18.3 % and 312 USD, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Find the stage where deals sit longest and work out what the buyer has to do there. It is almost always an internal approval, and the fix is material rather than persuasion.
It compresses the last step and does nothing to the stalls earlier in the cycle, which is where the time actually goes. It also teaches buyers that waiting is rewarded.
No, if the deal size and win rate justify it. It becomes a problem when the cycle is longer than your cash conversion allows, which is a financing constraint rather than a sales one.
Materially, yes. To reach 13.44 m usd revenue requires 6,720 enrolments yet incremental support costs erase 0.17 m usd of ebitda — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 14.4 %, 71 %, 18.3 %, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 14.4 % and 71 %. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית